Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Significant Growth in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Significant Growth in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 398,400 shares, an increase of 52.1% from the August 31st total of 262,000 shares. Based on an average daily trading volume, of 935,600 shares, the days-to-cover ratio is presently 0.4 days.
費森尤斯醫療保健股份公司KGaA(紐約證券交易所代碼:fms-GET評級)9月份空頭股數業務大幅增長。截至9月15日,空頭股數共有39.84萬股,比8月31日的26.2萬股增加了52.1%。以日均成交量935,600股計算,目前天數與回補比率為0.4天。
Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA
機構投資者看好Fresenius Medical Care AG&Co.KGaA
Several institutional investors and hedge funds have recently made changes to their positions in FMS. Dimensional Fund Advisors LP lifted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 1.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 53,824 shares of the company's stock worth $1,747,000 after buying an additional 516 shares during the period. Invesco Ltd. lifted its position in Fresenius Medical Care AG & Co. KGaA by 54.0% during the fourth quarter. Invesco Ltd. now owns 376,173 shares of the company's stock valued at $12,211,000 after purchasing an additional 131,870 shares during the period. Johnson Financial Group Inc. acquired a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter valued at $155,000. Sendero Wealth Management LLC acquired a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter valued at $391,000. Finally, Wulff Hansen & CO. acquired a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter valued at $351,000. 5.59% of the stock is currently owned by institutional investors and hedge funds.
幾家機構投資者和對衝基金最近改變了他們在FMS的頭寸。Dimenius Fund Advisors LP在第四季度增持了費森尤斯醫療保健公司(Fresenius Medical Care AG&Co.KGaA)1.0%的股份。Dimension Fund Advisors LP現在擁有53,824股該公司的股票,價值1,747,000美元,在此期間又購買了516股。第四季度,景順公司將其在Fresenius Medical Care AG&Co.KGaA的持股比例提高了54.0%。景順股份有限公司目前持有376,173股該公司股票,價值12,211,000美元,在此期間又購買了131,870股。約翰遜金融集團在第四季度收購了費森尤斯醫療保健股份公司的一個新頭寸,價值15.5萬美元。Sendero Wealth Management LLC在第四季度收購了費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的一個新頭寸,價值39.1萬美元。最後是Wulff Hansen&Co.第四季度收購了Fresenius Medical Care AG&Co.KGaA的一個新頭寸,價值351,000美元。5.59%的股票目前由機構投資者和對衝基金持有。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
FMS has been the topic of several research reports. Jefferies Financial Group raised shares of Fresenius Medical Care AG & Co. KGaA from an "underperform" rating to a "buy" rating and lifted their price objective for the company from $30.30 to $33.70 in a report on Monday, June 27th. JPMorgan Chase & Co. cut their price target on shares of Fresenius Medical Care AG & Co. KGaA from €51.00 ($52.04) to €23.00 ($23.47) in a report on Monday, August 1st. Truist Financial cut their price target on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a "hold" rating on the stock in a report on Wednesday, June 22nd. Berenberg Bank cut their price target on shares of Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a report on Wednesday, August 10th. Finally, UBS Group lowered shares of Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "neutral" rating in a report on Friday, July 29th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of "Hold" and an average target price of $45.83.
FMS已經成為幾份研究報告的主題。在6月27日星期一的一份報告中,傑富瑞金融集團將費森尤斯醫療保健股份公司的股票評級從表現不佳上調至買入,並將該公司的目標價從30.30美元上調至33.70美元。摩根大通在8月1日週一的一份報告中將費森尤斯醫療保健公司(Fresenius Medical Care AG&Co.KGaA)的目標股價從51.00歐元(合52.04美元)下調至23.00歐元(合23.47美元)。Truist Financial在6月22日週三的一份報告中將Fresenius Medical Care AG&Co.KGaA的股票目標價從34.00美元下調至27.00美元,並將該股的評級設定為持有。貝倫貝格銀行在8月10日週三的一份報告中將Fresenius Medical Care AG&Co.KGaA的目標價從76.70歐元(78.27美元)下調至57.95歐元(59.13美元)。最後,瑞銀集團在7月29日星期五的一份報告中將Fresenius Medical Care AG&Co.KGaA的股票評級從買入下調至中性。一位股票研究分析師將該股的評級定為賣出,8位分析師給出了持有評級,3位分析師給出了買入評級。根據MarketBeat.com的數據,Fresenius Medical Care AG&Co.KGaA目前的平均評級為持有,平均目標價為45.83美元。
Fresenius Medical Care AG & Co. KGaA Stock Performance
費森尤斯醫療保健股份公司KGaA股票表現
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.41 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.04). Fresenius Medical Care AG & Co. KGaA had a return on equity of 6.70% and a net margin of 4.42%. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.80 billion. Sell-side analysts predict that Fresenius Medical Care AG & Co. KGaA will post 1.64 EPS for the current year.
Fresenius Medical Care AG&Co.KGaA(紐約證券交易所代碼:FMS-GET Rating)最近一次公佈季度收益數據是在7月28日星期四。該公司公佈本季度每股收益為0.41美元,低於普遍預期的0.45美元(0.04美元)。費森尤斯醫療保健股份公司KGaA的股本回報率為6.70%,淨利潤率為4.42%。該公司本季度營收為50.7億美元,而分析師預期為48億美元。賣方分析師預計,費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)本年度每股收益將達到1.64股。
About Fresenius Medical Care AG & Co. KGaA
關於費森尤斯醫療保健股份公司
(Get Rating)
(獲取評級)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Fresenius Medical Care AG&Co KGaA在德國、北美和國際上提供透析護理和相關的透析護理服務。它通過門診透析診所網絡提供透析治療以及相關的實驗室和診斷服務;材料、培訓和患者支持服務,包括臨牀監測、後續援助和安排將用品運送到患者住所;以及根據合同向美國醫院提供為住院的終末期腎病(ESRD)患者和急性腎功能衰竭患者提供的透析服務。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- 免費獲取StockNews.com關於Fresenius Medical Care AG&Co.KGaA(FMS)的研究報告。
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat:回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 雷神工業走出谷底
- 利潤下降對CarMax價值主張的挑戰
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
接受Fresenius Medical Care AG&Co.KGaA Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Fresenius Medical Care AG&Co.KGaA和相關公司的最新新聞和分析師評級的每日簡要摘要。